Search

West Pharmaceutical Services Inc

Avatud

SektorTervishoid

370.22 -0.82

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

368.69

Max

382.23

Põhinäitajad

By Trading Economics

Sissetulek

15M

154M

Müük

27M

872M

P/E

Sektori keskmine

46.204

55.725

Aktsiakasum

2.37

Dividenditootlus

0.24

Kasumimarginaal

17.654

Töötajad

10,800

EBITDA

-39M

179M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+10.31% upside

Dividendid

By Acuity

Dividenditootlus

Sektori keskmine

0.24%

2.25%

Järgmine tulemuste avaldamine

22. okt 2026

Järgmine dividendimakse kuupäev

18. nov 2026

Järgmine aktsia dividendi kuupäev (ex-date)

11. nov 2026

Turustatistika

By TradingEconomics

Turukapital

570M

25B

Eelmine avamishind

371.04

Eelmine sulgemishind

370.22

Uudiste sentiment

By Acuity

100%

0%

307 / 339 Pingereas Healthcare

West Pharmaceutical Services Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. sept 2026, 22:40 UTC

West Pharmaceutical Services Inc declined in after-hours trading, reversing an initial gain, despite remaining above its 20-day moving average.

23. sept 2026, 23:51 UTC

West Pharmaceutical Services Inc is seeing a modest decline in after-market trading, positioned at the lower end of today's range but above its 20-day moving average.

22. sept 2026, 20:02 UTC

News

Morgan Stanley upgraded West Pharmaceutical Services Inc to Overweight and raised its price target to $400, contributing to a significant rise in the stock.

18. sept 2026, 20:03 UTC

West Pharmaceutical Services Inc shares fell sharply, reversing from an earlier peak to drop to their lowest point late in the morning amid a broader decline.

17. sept 2026, 22:41 UTC

West Pharmaceutical Services Inc is experiencing a modest decline in after-market trading, moving lower alongside the broader market's significant downward movement.

16. sept 2026, 20:13 UTC

West Pharmaceutical Services Inc is advancing in after-market trading, significantly above its 20-day moving average since Wednesday's close.

15. sept 2026, 20:13 UTC

West Pharmaceutical Services shares are lower in after-market hours amid negative market sentiment and concerns over economic momentum and potential interest rate hikes.

14. sept 2026, 20:07 UTC

News

West Pharmaceutical Services is gaining as CFO discusses strong second-quarter results at the Morgan Stanley conference, despite a recent cyber incident.

11. sept 2026, 20:01 UTC

News

UBS raised West Pharmaceutical Services' price target to $415, maintaining a "buy" rating. Shares are higher since Thursday's close despite earlier session declines.

10. sept 2026, 20:51 UTC

West Pharmaceutical Services Inc shares are lower in after-market hours amid challenging broader market conditions and declining existing home sales for August.

9. sept 2026, 20:07 UTC

West Pharmaceutical Services Inc. trades roughly flat amid a broader market trend, remaining near the lower end of its one-month range.

8. sept 2026, 23:26 UTC

West Pharmaceutical Services Inc. shares are higher in after-market trading, showing modest gains since Tuesday's close despite no specific news to explain the movement.

4. sept 2026, 19:36 UTC

West Pharmaceutical Services is declining amid broader market pressure from strong labor data and rising Treasury yields, with shares below their 20-day moving average.

3. sept 2026, 22:01 UTC

West Pharmaceutical Services shares are higher in after-market trading as Treasury yields decline, easing concerns about rising borrowing costs impacting growth stocks.

2. sept 2026, 23:51 UTC

West Pharmaceutical Services Inc shares are higher in after-market trading. The move occurs amid a weaker-than-expected ADP payrolls report, easing rate hike concerns.

1. sept 2026, 23:51 UTC

West Pharmaceutical Services Inc shares are lower in after-hours trading, continuing a downward trend and trading below the 20-day moving average.

31. aug 2026, 20:07 UTC

News

West Pharmaceutical Services is higher, reflecting institutional trading activity amid expectations for interest rate hikes following the Jackson Hole Economic Symposium.

28. aug 2026, 23:11 UTC

West Pharmaceutical Services shares are higher in after-market trading, reaching a session high but remaining below their 20-day moving average.

27. aug 2026, 23:02 UTC

West Pharmaceutical Services Inc shares are higher in after-market hours. The broader market reflects a decline in initial jobless claims, indicating labor market strength.

26. aug 2026, 19:26 UTC

West Pharmaceutical Services Inc is trading higher amid positive market conditions, despite no specific company news driving today's activity.

25. aug 2026, 23:26 UTC

West Pharmaceutical Services Inc. shares are trading roughly flat after hours, amid broader market stability following a significant decline in crude oil prices.

24. aug 2026, 19:51 UTC

West Pharmaceutical Services Inc is trading higher today, remaining near the upper end of its one-month range and above its 20-day moving average.

21. aug 2026, 23:01 UTC

West Pharmaceutical Services Inc. shares are lower in after-market trading, remaining near the lower end of today's range and the upper end of their one-month range.

20. aug 2026, 20:06 UTC

West Pharmaceutical Services Inc shares are higher, continuing an upward trend since Wednesday. Broader market trends may be influencing investor sentiment in the life sciences sector.

19. aug 2026, 20:06 UTC

West Pharmaceutical Services Inc shares are rising amid a positive market backdrop, remaining above their 20-day moving average and near the upper end of their one-month range.

18. aug 2026, 19:36 UTC

West Pharmaceutical Services Inc. is trading slightly higher, maintaining a routine move within its one-month trading range. No specific news was identified.

17. aug 2026, 22:55 UTC

West Pharmaceutical Services shares are slightly higher in after-market hours, amid escalating geopolitical tensions and rising crude oil prices affecting market stability.

14. aug 2026, 23:01 UTC

West Pharmaceutical Services shares are lower in after-market hours, influenced by a decline in U.S. retail sales for July. No specific news was identified.

13. aug 2026, 23:36 UTC

West Pharmaceutical Services Inc. shares declined after-market, with no specific company news identified. Broader market sentiment may be influenced by unchanged producer prices.

12. aug 2026, 19:36 UTC

West Pharmaceutical Services is trading higher, supported by a slight increase in the core Consumer Price Index and an optimistic outlook for risk assets.

Võrdlus sarnastega

Hinnamuutus

West Pharmaceutical Services Inc Prognoos

Hinnasiht

By TipRanks

10.31% tõus

12 kuu keskmine prognoos

Keskmine 412.111 USD  10.31%

Kõrge 447 USD

Madal 390 USD

Põhineb 10 Wall Streeti analüütiku instrumendi West Pharmaceutical Services Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

10 ratings

10

Osta

0

Hoia

0

Müü

Sentiment

By Acuity

307 / 339 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.